How should I evaluate and manage a 42-year-old female with anxiety presenting with acute shortness of breath and palpitations?

Immediate Evaluation and Management of Acute Shortness of Breath and Palpitations in a 42-Year-Old Female with Anxiety

You must first rule out cardiac arrhythmia with an ECG immediately—do not assume this is anxiety until proven otherwise. A 42-year-old woman presenting with acute palpitations and shortness of breath requires urgent cardiovascular evaluation regardless of her anxiety history, as cardiac arrhythmias (particularly supraventricular tachycardia) can be misdiagnosed as panic attacks 1.

Critical First Steps: Rule Out Medical Causes

Obtain an ECG within minutes of presentation. The most important pitfall in this scenario is attributing symptoms to anxiety without excluding life-threatening cardiac conditions. Look specifically for:

• Heart rate and rhythm: SVT typically presents with sustained heart rates >150 bpm (can reach 217 bpm as documented in misdiagnosed cases) 1
• QT interval: Check for prolongation
• ST-segment changes: Rule out acute coronary syndrome
• Narrow vs. wide complex tachycardia: Narrow complex suggests SVT

Physical examination must identify:

• Sustained tachycardia (>100 bpm at rest)
• Tachypnea (respiratory rate >20)
• Oxygen saturation <94%
• Signs of heart failure (crackles, elevated JVP, peripheral edema)
• Trembling, sweating, or sweaty palms (can indicate either cardiac or anxiety etiology) 2

Laboratory evaluation should include:

• Troponin (rule out myocardial infarction)
• Thyroid function tests (hyperthyroidism causes both anxiety and palpitations)
• Electrolytes (hypokalemia, hypomagnesemia can cause arrhythmias)
• Complete blood count (anemia causes dyspnea)
• Drug/alcohol screen if substance use suspected 3, 2

If Cardiac Workup is Negative: Assess Anxiety Severity

Once medical causes are excluded, use the GAD-7 scale to quantify anxiety severity 2, 3:

• Score 0-4 (none/mild): Supportive care, reassurance, breathing techniques
• Score 5-9 (moderate): Consider pharmacologic or psychological intervention
• Score 10-14 (moderate-to-severe): Requires treatment—pharmacologic and/or psychological therapy
• Score 15-21 (severe): Requires immediate treatment and possible psychiatric referral

Key anxiety symptoms to identify 2:

• Panic attacks (sudden onset, peaks within 10 minutes)
• Excessive worry disproportionate to actual risk
• Physical symptoms: trembling, sweating, tachypnea, tachycardia, palpitations
• Functional impairment in work, social, or personal relationships
• Duration and frequency of episodes

Immediate Symptom Management

For Acute Anxiety with Palpitations/Dyspnea (After Cardiac Causes Excluded):

First-line acute management 4:

• Lorazepam 0.5-1 mg orally (can be used sublingually)
• Maximum 4 mg in 24 hours
• Reduce to 0.25-0.5 mg in elderly patients

Non-pharmacologic interventions 4:

• Explore the patient's specific concerns and anxieties
• Provide clear explanation of what is happening physiologically
• Teach controlled breathing techniques (slow, deep breaths)
• Ensure adequate lighting and calm environment
• Reassure that symptoms, while distressing, are not life-threatening once cardiac causes excluded

Ongoing Treatment Plan

For Moderate-to-Severe Anxiety (GAD-7 ≥10):

Pharmacologic options 5:

• SSRIs (first-line): Sertraline starting 25-50 mg daily, titrate to 50-200 mg
• SNRIs (first-line): Venlafaxine XR starting 37.5-75 mg daily, titrate to 75-225 mg
• Effect size vs. placebo: SMD -0.55 for generalized anxiety disorder 5

Psychological therapy (first-line) 5, 6:

• Cognitive Behavioral Therapy (CBT): Most evidence-based psychotherapy
• Effect size: Hedges g = 1.01 (large effect) for generalized anxiety disorder 5
• Can be delivered in primary care settings
• Typically 12-16 sessions

Critical warning about benzodiazepines 3: While effective for acute symptoms, benzodiazepines carry significant risks:

• Abuse and dependence potential
• Cognitive impairment
• Should be time-limited only (days to weeks, not months)
• Use only as bridge to SSRI/SNRI or CBT

Treatment Selection Algorithm:

1. Patient prefers medication: Start SSRI or SNRI
2. Patient prefers non-medication: Refer for CBT
3. Severe symptoms with functional impairment: Combine SSRI/SNRI + CBT
4. Acute crisis: Short-term benzodiazepine (≤2 weeks) + start SSRI/SNRI simultaneously

Follow-Up and Reassessment

Monthly monitoring required 3:

• Assess medication compliance and side effects
• Reassess GAD-7 score
• Evaluate functional improvement in daily activities
• Monitor for suicidal ideation (anxiety disorders increase suicide risk) 7

After 8 weeks of treatment 3:

• If poor symptom reduction despite good compliance: alter treatment
  • Add psychological intervention if on medication alone
  • Change medication class
  • Add medication if doing CBT alone
  • Refer to psychiatry if refractory

Consider psychiatric referral immediately if 2:

• Risk of harm to self or others
• Severe agitation
• Psychosis or confusion
• No response to initial treatment
• Comorbid substance use disorder

Special Considerations for This Patient

Given her significant social stressors, address these specifically:

• Identify specific stressors (work, relationships, financial, family)
• Problem-solve around modifiable stressors
• Connect with social work if needed for resource assistance
• Consider whether stressors are acute (may resolve) vs. chronic (require long-term coping strategies)

Documentation should include:

• Specific cardiac findings that ruled out arrhythmia
• GAD-7 score
• Functional impairment level
• Treatment plan with specific follow-up interval
• Safety assessment (suicidal ideation, self-harm risk)

The key to this case is never assuming anxiety until cardiac causes are definitively excluded 1, then providing evidence-based treatment that combines both immediate symptom relief and long-term management with SSRIs/SNRIs and/or CBT 5.